BRITTNI CHITWOOD: Open Payments
NPI 1588150429 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,822 in 131 payments from 16 companies in 2025. Trend: 2023 $2,400 · 2024 $2,589 · 2025 $2,822
Food & beverage: $2,624Education: $198
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 27 | $404 |
| Regeneron Healthcare Solutions, Inc. | 10 | $392 |
| ABBVIE INC. | 25 | $328 |
| Galderma Laboratories, L.P. | 10 | $283 |
| GENZYME CORPORATION | 13 | $236 |
| Amgen Inc. | 7 | $214 |
| Janssen Biotech, Inc. | 9 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $196 |
| Organon LLC | 4 | $153 |
| Organogenesis Inc. | 4 | $89 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, OTEZLA, TREMFYA, RINVOQ, Winlevi, VTAMA.
Industry payments across GA — which companies pay providers there.
